Cyclophosphamide-induced teratogenesis in ICR mice: the role of apoptosis.
It is known that programmed cell death (apoptosis) is an important physiological determinant of embryonic development. In parallel, it may be one of the major events involved in induced teratogenesis. The present study was designated to evaluate to what extent is apoptosis involved in the formation of some final abnormalities induced by cyclophosphamide (CP) in ICR mice. The level of apoptosis in limbs, tail, liver, and whole embryo was assessed 24 h after administration of various doses of CP (day 12 of pregnancy) by flow cytometric analysis and by DNA fragmentation assay. In parallel, the rate of limb and tail malformations, resorptions, and growth retardation induced by various doses of CP was evaluated in animals sacrificed on day 19 of pregnancy using routine teratological methods. A striking correlation between the rate of CP-induced apoptosis in limb and tail cells and the severity of limb and tail anomalies was found after administration of CP ranging from 10 to 40 mg/kg. Thus, the percent of apoptotic cells collected from limbs and tails increased from 18 to 78%. In parallel, the severity of limb and tail anomalies increased from digit anomalies to amely and from crooked to short or absent tail. CP-induced embryolethality and fetal growth retardation also correlated with the level of apoptosis in cells collected from whole embryos but to a lesser extent. These results claim that CP-induced apoptosis is one of the inevitable events in the pathway leading to the formation of CP-induced abnormalities and also suggest that the extent of the involvement of apoptosis in the formation of different types of final abnormalities, may be different.
Torchinsky
A
A
Department of Embryology and Teratology, Tel-Aviv University, Israel.
Savion
S
S
Gorivodsky
M
M
Shepshelovich
J
J
Zaslavsky
Z
Z
Fein
A
A
Toder
V
V
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000633:toxicity*; D017209:Apoptosis / Q000187:drug effects*; D003520:Cyclophosphamide / Q000633:toxicity*; D004249:DNA Damage; D005260:Female; D005327:Fetal Resorption / Q000139:chemically induced; D005434:Flow Cytometry; D017880:Limb Deformities, Congenital; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D011247:Pregnancy
D000964:Antimetabolites, Antineoplastic; D003520:Cyclophosphamide